To explore the effect of PDK4 on cell growth and rituximab resistance in DLBCL cells, two shRNA sequences (shRNA1 and shRNA2) targeting human PDK4 were designed. This evidence concerns the gene PDK4 and diffuse large B-cell lymphoma.